Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

October 10, 2006

Primary Completion Date

October 27, 2008

Study Completion Date

October 27, 2008

Conditions
NeoplasmsNauseaVomiting
Interventions
DRUG

Palonosetron and Dexamethasone

0.25 mg IV single dose, 30 minutes prior to the administration of the major chemotherapeutic agent, plus single IV dose of dexamethasone 8 mg administered 15 minutes before chemotherapy (in the event of a shortage of IV dexamethasone, a single oral dose of dexamethasone 20 mg or a single IV dose of methylprednisolone 125 mg could be administered).

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00687011 - Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594) | Biotech Hunter | Biotech Hunter